Skip to main content
. 2016 Jul 22;89(1065):20160232. doi: 10.1259/bjr.20160232

Table 1.

Patient data and measured microvessel density (MVD) and image parameters (uptake, contrast and type of time curves)

Patient data
Pathology
MVD (vessels per field)
Contrast-enhanced digital mammography results
ID Age (years) Malignant/benign Lesion type BMVD LMVD Iodine uptake at t = 3 min (mg iodine/cm2) Time–iodine curve Contrast at t = 3 min (mg iodine/cm2) Time–contrast curve
1 68 M IDCn 48.8 23.6 2.62 2 1.89 2
3 44 B BF 17.8 7.6 0.55 5 −0.85 4
4 62 M IDC 49.8 28.4 1.06 2 1.25 2
5 40 B BF 23.8 6.6 1.78 1 1.18 1
6 54 M IDC 67.4 41.2 1.75 3 2.17 3
7 50 B BF 21.2 11.0 5.68 2 3.65 2
8 47 B BA 27.2 14.6 1.54 2 0.77 2
9 60 M IDC 60.6 46.6 −0.98 4 −0.64 4
11 56 M IDC 45.2 17.0 1.83 1 1.05 1
12 61 M DCIS 46.0 26.2 −0.84 4 −0.44 5
14 62 M IDC 55.6 34.6 0.95 3 −0.40 5
15 45 M IDC 43.6 33.8 0.44 5 −0.44 5
18 39 B BF 20.2 8.0 1.51 2 1.68 2
21 42 B BF 22.6 9.8 0.30 5 0.54 5
23 36 B BF 20.0 5.6 4.95 2 3.77 2
24 38 M IDCn 63.2 40.4 3.51 2 1.98 3
25 63 M IDCn 59.0 43.4 4.69 2 4.22 2
26 59 M IDC 60.6 33.6 1.38 2 1.48 2

B, benign; BA, microglandular adenosis; BF, fibroadenoma; BMVD, blood MVD; DCIS, ductal carcinoma in situ; ID, identification; IDC, invasive ductal carcinoma; IDCn, IDC with necrosis; LMVD, lymph MVD; M, malignant.

Only information related to the 18 patients included in the study is shown; the listed patient identification corresponds to the enrolment sequence.